{"schema_version":"1","generated_at":"2026-11-17T10:20:16.536Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/david-ettinger","json_url":"https://www.findmykol.com/kol/david-ettinger/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"david-ettinger","name":"David Ettinger","credential":"MD","title":"Alex Grass professor of Oncology","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Lung","therapeutic_areas":["Lung","Oncology"],"institution":"Johns Hopkins School of Medicine","institution_url":"https://www.findmykol.com/institution/johns-hopkins-university-school-of-medicine","city":"Lutherville","state":"MD","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1720016777"},"summary":"David Ettinger is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.","overview":{"text":"David Ettinger, M.D., is Alex Grass professor of Oncology at Johns Hopkins School of Medicine. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (1985–1997).","bullets":["Top research focus: Lung Cancer (NSCLC/SCLC)","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 2 companies"],"generated_at":"2026-11-16"},"focus":{"indications":[{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Adenocarcinoma of Lung","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Small Cell Lung Carcinoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Thymoma","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Lung Cancer (NSCLC/SCLC)","Adenocarcinoma of Lung","Small Cell Lung Carcinoma","Thymoma"],"drugs_studied":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Spevigo","generic":"Spesolimab","trials":0,"payments":2,"publications":0,"mentions":2},{"name":"Inlyta","generic":"Axitinib","trials":0,"payments":1,"publications":0,"mentions":1}]},"works_with":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"Boehringer Ingelheim Pharmaceuticals, Inc.","trials":0,"payments":2,"mentions":2},{"name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","trials":2,"payments":0,"mentions":2},{"name":"Eastern Cooperative Oncology Group","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT01752023","title":"A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.","phase":"PHASE2","status":"TERMINATED","role":"Investigator","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT01752023","trial_url":"https://www.findmykol.com/trial/NCT01752023"},{"nct":"NCT01578551","title":"Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.","phase":"PHASE2","status":"TERMINATED","role":"Investigator","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","source_url":"https://clinicaltrials.gov/study/NCT01578551","trial_url":"https://www.findmykol.com/trial/NCT01578551"},{"nct":"NCT00003283","title":"Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Eastern Cooperative Oncology Group","source_url":"https://clinicaltrials.gov/study/NCT00003283","trial_url":"https://www.findmykol.com/trial/NCT00003283"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2022,"last":2023},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Boehringer Ingelheim Pharmaceuticals, Inc.","program_year":2023,"amount_usd":37.35,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1720016777"},{"payer":"PFIZER INC.","program_year":2022,"amount_usd":25.52,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1720016777"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1720016777","source":"payments"},"funding":{"award_count":6,"fiscal_years":{"first":1985,"last":1997},"rows_total":29,"shown":3,"withheld":26,"rows":[{"project":"M01RR000052","title":"9-AMINO-(20(S))-CAMPTOTECIN (9AC) IN ADVANCED NON-SMALL CELL LUNG CANCER","fiscal_year":1997,"organization":"JOHNS HOPKINS UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/M01RR000052"},{"project":"N01CO003862","title":"CANCER INFORMATION SERVICE","fiscal_year":1993,"organization":"JOHNS HOPKINS UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/N01CO003862"},{"project":"N01CO003862","title":"CANCER INFORMATION SERVICE","fiscal_year":1992,"organization":"JOHNS HOPKINS UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/N01CO003862"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, FACP, FCCP","source_url":"https://d17k4s9qki18rb.cloudfront.net/media/uploads/ORO/lung-early-stage-patient.pdf","status":"provisional","collected_at":"2026-11-13"}]},"roles":{"total":2,"shown":2,"rows":[{"value":"Chaired NCCN non-small-cell lung cancer guidelines panel","source_url":"https://www.cancernetwork.com/view/interviews-show-positive-response-nccns-cancer-guidelines","status":"provisional","collected_at":"2026-11-13"},{"value":"Co-Chair, Lung Cancer Committee","source_url":"https://www.sciencedirect.com/science/article/abs/pii/S0360301601017795","status":"provisional","collected_at":"2026-11-13"}]},"media":{"total":1,"shown":1,"rows":[{"value":"OncLive interview: Dr. David Ettinger Discusses the Road Ahead for Immunotherapy in NSCLC","source_url":"https://www.onclive.com/view/dr-david-ettinger-discusses-the-road-ahead-for-immunotherapy-in-nsclc","status":"provisional","collected_at":"2026-11-13"}]}},"similar":[{"name":"Myron Weisfeldt","slug":"myron-weisfeldt","institution":"Johns Hopkins School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/myron-weisfeldt","json_url":"https://www.findmykol.com/kol/myron-weisfeldt/profile.json"},{"name":"Arthur Burnett","slug":"arthur-burnett","institution":"Johns Hopkins School of Medicine","specialty":"Urology","url":"https://www.findmykol.com/kol/arthur-burnett","json_url":"https://www.findmykol.com/kol/arthur-burnett/profile.json"},{"name":"Richard Jones","slug":"richard-jones","institution":"Johns Hopkins School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/richard-jones","json_url":"https://www.findmykol.com/kol/richard-jones/profile.json"},{"name":"Matthias Holdhoff","slug":"matthias-holdhoff","institution":"Johns Hopkins School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/matthias-holdhoff","json_url":"https://www.findmykol.com/kol/matthias-holdhoff/profile.json"},{"name":"Marc Ladanyi","slug":"marc-ladanyi","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Anatomic Pathology","url":"https://www.findmykol.com/kol/marc-ladanyi","json_url":"https://www.findmykol.com/kol/marc-ladanyi/profile.json"},{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Pasi Janne","slug":"pasi-janne","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/pasi-janne","json_url":"https://www.findmykol.com/kol/pasi-janne/profile.json"},{"name":"John Minna","slug":"john-minna","institution":"University of Texas Southwestern Medical Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/john-minna","json_url":"https://www.findmykol.com/kol/john-minna/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"funding":26}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-13"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2023","collected_at":"2026-11-13"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-13"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}